Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bioengineers Present Glucose Monitor Tattoo Prototype

By LabMedica International staff writers
Posted on 25 Jan 2015
Print article
Image: Bioengineers have tested a flexible and easy to wear temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells (Photo courtesy of the University of California, San Diego).
Image: Bioengineers have tested a flexible and easy to wear temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells (Photo courtesy of the University of California, San Diego).
A team of bioengineers has presented a prototype "proof-of-concept" version of a temporary tattoo that is able to extract and measure the level of glucose in the fluid between human skin cells.

The flexible, easy to wear device consists of a pattern of electrodes printed on temporary tattoo paper that is attached to the skin. When a mild electrical current is applied to the skin for about 10 minutes, sodium ions and glucose molecules in the interstitial fluid migrate toward the tattoo's electrodes. A sensor built into the tattoo measures the strength of the electrical charge produced by the glucose to determine the patient's overall glucose level.

In a preliminary study, tattoos were applied to seven men and women between the ages of 20 and 40 with no history of diabetes. The volunteers were fed a carbohydrate-rich meal, and glucose levels were monitored by the tattoo and compared to those obtained by the traditional finger-stick method. Results showed that the tattoos detected the glucose spike following the meal with the same level of accuracy as the finger-stick.

"The concentration of glucose extracted by the noninvasive tattoo device is almost hundred times lower than the corresponding level in the human blood," said first author Amay Bandodkar, a graduate researcher at the University of California, San Diego (USA). "Thus we had to develop a highly sensitive glucose sensor that could detect such low levels of glucose with high selectivity. Eventually the instrument will also have Bluetooth readout capabilities to send this information directly to the patient's doctor in real-time or store data in the cloud. Presently the tattoo sensor can easily survive for a day. These are extremely inexpensive—a few cents—and hence can be replaced without much financial burden on the patient."

The paper describing the potential for glucose monitoring with a noninvasive flexible tattoo was published in the December 12, 2014, online edition of the journal Analytical Chemistry.

Related Links:

University of California, San Diego


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.